2nd International Congress on Phagocytes biological and clinical aspects

[Piero Micheletti]

2nd International Congress on Phagocytes biological and clinical aspects


                          First Announcement


                  September 4-7, 1996 Pavia Italy

-------------------------------------------------------------------------

Web resource is available at:

http://www.unipv.it/~webmed/congress/phagocyt/home.htm

-------------------------------------------------------------------------

The future economic and social well-being of scientific institutions 
requires an effective and competitive research system. The aims of our 
Congress are to bring together scientists with an interest in phagocyte 
and inflammation research, and to encourage the discussion of scientific 
and technological advances that can be used to discover and develop new 
therapeutic advances, both for diseases involving phagocytes, and for 
phagocyte related diseases. Phagocytes is a very hot topic in the world 
of inflammation and cellular biology research. Uniting foundamental and 
clinical researchers, the congress will address a large range of issues 
inherent to phagocytes: their physiology and molecular biology, their 
involvement in human diseases and new therapeutic procedures. 
Multidisciplinary research including cellular, molecular, genetic and 
clinical approaches, will be presented in order to deepen understanding 
of the physiopathological mechanisms that lead to the development of 
phagocyte diseases and of phagocyte related diseases. Improvement in 
phagocyte defect diagnosis, therapy and prevention requires the 
integration to basic and clinical approaches to research. It is therefore 
particularly important to bring new advances in cellular, molecular and 
developmental genetics into contact with inflammatory diseases, 
inflammation and epidemiology, in order that new biological insights into 
the underlying causes of inflammation allow for the development of 
interactive novel approaches. Studies of host phagocyte interaction in 
the context of immune response will be presented, together with 
pharmacological and clinical studies on possible causative factors and on 
the role of phagocytes in infectious and non infectious diseases.

-------------------------------------------------------------------------

More information are available from:

Prof. Giovanni Ricevuti

Institute of Medical Therapy
IRCCS Policlinico S. Matteo
Pavia, Italy
tel. +39.382.502499
fax. +39.382.526341
e-mail:termedpv at ipv36.unipv.it
       mikimos at mbox.vol.it